FDA Investigator Dylan R Jock
Dylan R Jock has inspections in 1 countries as of 29 Sep 2023. Dylan R Jock has collaborated with a combined 1168 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
24
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amy A Johnson,
Arsen Karapetyan,
Barbara D Wright,
Celeta S Coves,
Claude L Brunson,
Comyar Shoghi,
Courtney N Long,
Creighton T Tuzon,
Daniell Gill, Jr,
Diana L Ayala,
Doretha M Tonkins,
Doretha M Wilson,
Eddie J Rigsby,
Elmina E Akwo,
Elmina E Mboh,
Emily B Camire,
Ernest Serna, III,
Gabriel M Guevarra,
Gail L Katz,
Gene D Arcy,
Gloria A Milster,
Hoimay Chan,
Iris C Macinnes,
Janet B Abt,
Jerry E Lott,
Juanelma H Palmer,
Julian C Hanson,
Ka L Wong,
Karen J Bak,
Kenneth L Smalls,
Lakecha N Lewis,
Laurissa S Flowers,
Leeterry Moore,
Linda Thai,
Maira P Brading,
Marion W Nadeau,
Mark W Rivero,
Mary Ewilkerson Brinsko,
Mizanne E Lewis,
Naveen B Walker,
Nikisha M Bolden,
Pauline N Logan,
Peter Kessler, PhD,
Randy D Baxter,
Raymond W Brullo,
Rebeca Ulloa,
Richard J Bashay,
Robert S Sweeton,
Ronda R Loyd Jones,
Roosevelt Turner,
Sandra Jacquez,
Sarah Forney,
Shaquenta Y Perkins,
Sidney M Smith,
Sonya L Karsik,
Steven E Porter, Jr,
Tania Y Hall,
Tawny L Colling,
Thao T Kwan,
Tiana M Mckinley,
Timothy P Lafave,
Tracy J Washington,
Trushani T Desai,
Verdell Nelson,
Vien Q Le,
Vivian Garcia,
Young M Yoon,
Yvette Mlacour Davis,
Yvette S Montes,
Yvonne C Wilkes
Dylan R Jock's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2023 | FDA 483 | University Fertility Laboratory, Inc. - Form 483, 2023-04-03 |
May, 2023 | FDA 483 | Incinta Fertility Center, LLC - Form 483, 2023-05-02 |
August, 2022 | FDA 483 | Cedars-Sinai Medical Center - Form 483, 2022-08-26 |
February, 2024 | FDA 483 | CSL Plasma Inc. - Form 483, 2024-02-01 |
February, 2024 | FDA 483 | Peyman Saadat MD, Inc. - Form 483, 2024-02-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more